Eurolab’s state of the art SAHPRA-approved sterile cGMP facility improves access to quality oncology treatments
Eurolab’s Aseptic Services Unit (ASU) is located in Midrand, Johannesburg, and has a core business focus on centralized sterile oncology admixing. It is South Africa’s first South African Health Products Regulatory Authority (SAHPRA)-approved centralised sterile admixing facility and is modelled on international best practice facilities in the United Kingdom, Europe and Australia. Its centralized admixing facility offers significant benefits to both oncologists and patients across South Africa by improving access to quality assured chemotherapy. The ASU offers a centralised mixing service for sterile oncology medicines, the preparation of advanced therapeutic medicinal products and the preparation of sterile clinical trial medicines.
“Our Aseptic Services Unit is aligned with universal health access programmes such as the UK’s National Health Service (NHS). We do not compromise on quality and enhance the practice of pharmaceutical care to achieve improved patient treatment outcomes. In SA, we are a collaborating centre for the University of Witwatersrand and the University of Pretoria.” – Gavin Steel, GM of Eurolab’s ASU.